A paradigm shift in U.S. Breast reconstruction: Increasing implant rates

Plastic and Reconstructive Surgery

Volumn 131, Issue 1, 2013, Pages 15-23

  Albornoz, Claudia R ^a   Bach, Peter B ^a   Mehrara, Babak J ^a   Disa, Joseph J ^a   Pusic, Andrea L ^a   McCarthy, Colleen M ^a   Cordeiro, Peter G ^a   Matros, Evan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST AUGMENTATION; BREAST RECONSTRUCTION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MASTECTOMY; METHODOLOGY; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

BREAST IMPLANTATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MAMMAPLASTY; MASTECTOMY; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; UNITED STATES;

EID: 84872091047     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182729cde     Document Type: Article

References (50)

1. Tuttle TM, Rueth NM, Abbott A, Virnig BA. Trends in the local treatment of breast cancer: Should we be worried? J Surg Oncol. 2011;103:313-316.
2. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28:3437-3441.
3. Alderman AK, McMahon L Jr, Wilkins EG. The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg. 2003;111:695-703; discussion 704-705.
4. Wilkins EG, Alderman AK. Breast reconstruction practices in North America: Current trends and future priorities. Semin Plast Surg. 2004;18:149-155.
5. Polednak AP. Postmastectomy breast reconstruction in Connecticut: Trends and predictors. Plast Reconstr Surg. 1999; 104:669-673.
6. Reuben BC, Manwaring J, Neumayer LA. Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg. 2009;198:237-243.
7. Nano MT, Gill PG, Kollias J, Bochner MA, Malycha P, Winefield HR. Psychological impact and cosmetic outcome of surgical breast cancer strategies. ANZ J Surg. 2005;75:940-947.
8. Mock V. Body image in women treated for breast cancer. Nurs Res. 1993;42:153-157.
9. Stevens LA, McGrath MH, Druss RG, Kister SJ, Gump FE, Forde KA. The psychological impact of immediate breast reconstruction for women with early breast cancer. Plast Reconstr Surg. 1984;73:619-628.
10. Rowland JH, Holland JC, Chaglassian T, Kinne D. Psychological response to breast reconstruction: Expectations for and impact on postmastectomy functioning. Psychosomatics 1993;34:241-250.
11. Schain WS. Breast reconstruction: Update of psychosocial and pragmatic concerns. Cancer 1991;68:1170-1175.
12. Wilkins EG, Cederna PS, Lowery JC, et al. Prospective analysis of psychosocial outcomes in breast reconstruction: One-year postoperative results from the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg. 2000;106:1014-1025; discussion 1026-1027.
13. Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: Two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg. 2008;247:1019-1028.
14. Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act. JAMA 2006;295:387-388.
15. Agarwal S, Pappas L, Neumayer L, Agarwal J. An analysis of immediate postmastectomy breast reconstruction frequency using the surveillance, epidemiology, and end results database. Breast J. 2011;17:352-358.
16. Albornoz CR, Bach PB, Pusic AL, et al. The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: AUnited States population based study. Plast Reconstr Surg. 2012;129:1071-1079.
17. Polednak AP. Type of breast reconstructive surgery among breast cancer patients: A population-based study. Plast Reconstr Surg. 2001;108:1600-1603.
18. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS), 2008. Rockville, Md: Agency for Healthcare Research and Quality. Available at: http://www.hcup-us. ahrq.gov/nisoverview.jsp. Accessed July 2011.
19. Lentol J. Information and access to breast reconstructive surgery law. Committee on codes. 2010. Chapter 354; Health. A. 10094-B/S. 6993-B. Available at: http://assembly.state.ny.us/comm/Codes/2010Annual/index.pdf. Accessed July 2011.
20. Garfein ES. The privilege of advocacy: Legislating awareness of breast reconstruction. Plast Reconstr Surg. 2011;128:803- 804.
21. Hu ES, Pusic AL, Waljee JF, et al. Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship period. Plast Reconstr Surg. 2009;124:1-8.
22. Yueh JH, Slavin SA, Adesiyun T, et al. Patient satisfaction in postmastectomy breast reconstruction: A comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg. 2010;125:1585-1595.
23. Blondeel N, Vanderstraeten GG, Monstrey SJ, et al. The donor site morbidity of free DIEP flaps and free TRAM flaps for breast reconstruction. Br J Plast Surg. 1997;50:322-330.
24. Bottero L, Lefaucheur JP, Fadhul S, Raulo Y, Collins ED, Lantieri L. Electromyographic assessment of rectus abdominis muscle function after deep inferior epigastric perforator flap surgery. Plast Reconstr Surg. 2004;113:156-161.
25. U.S. Food and Drug Administration. Regulatory history of breast implants in the U.S. Available at: http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/Implant sandProsthetics/BreastImplants/ucm064461. htm. Accessed November 1, 2011.
26. Gopie JP, Hilhorst MT, Kleijne A, et al. Women's motives to opt for either implant or DIEP-flap breast reconstruction. J Plast Reconstr Aesthet Surg. 2011;64:1062-1067.
27. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
28. Ho A, Cordeiro P, Disa J, et al. Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation. Cancer 2011;118:2552-2559.
29. McCarthy CM, Pusic AL, Disa JJ, McCormick BL, Montgomery LL, Cordeiro PG. Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: A prospective outcomes analysis. Plast Reconstr Surg. 2005;116:1642-1647.
30. Roostaeian J, Pavone L, Da Lio A, Lipa J, Festekjian J, Crisera C. Immediate placement of implants in breast reconstruction: Patient selection and outcomes. Plast Reconstr Surg. 2011;127:1407-1416.
31. Jewell M, Spear SL, Largent J, Oefelein MG, Adams WP Jr. Anaplastic large T-cell lymphoma and breast implants: A review of the literature. Plast Reconstr Surg. 2011;128:651-661.
32. Smith TJ, Ramsaroop R. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast 2012;21:102-104.
33. Lazzeri D, Agostini T, Bocci G, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: A new clinical entity. Clin Breast Cancer 2011;11:283-296.
34. Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: Results from a structured expert consultation process. Plast Reconstr Surg. 2011;128:629-639.
35. Eaves FF, Haeck PC, Rohrich RJ. Breast implants and anaplastic large cell lymphoma: Using science to guide our patients and plastic surgeons worldwide. Plast Reconstr Surg. 2011;127:2501-2503.
36. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300: 2030-2035.
37. Zeidler KR, Hernandez-Boussard T, Barzin A, Lee GK, Curtin C. The impact of declining reimbursements on women's choices for breast reconstruction: National trends and healthcare implications. Paper presented at: 90th Annual Meeting of the American Association of Plastic Surgeons; April 9 through 12, 2012; Boca Raton, Florida. Available at: http://meeting. aaps1921.org/abstracts/ 2011/13.cgi. Accessed November 1, 2011.
38. Alderman AK, Storey AF, Nair NS, Chung KC. Financial impact of breast reconstruction on an academic surgical practice. Plast Reconstr Surg. 2009;123:1408-1413.
39. Vyas RM, Dickinson BP, Fastekjian JH, Watson JP, Dalio AL, Crisera CA. Risk factors for abdominal donor-site morbidity in free flap breast reconstruction. Plast Reconstr Surg. 2008; 121:1519-1526.
40. Ascherman JA, Seruya M, Bartsich SA. Abdominal wall morbidity following unilateral and bilateral breast reconstruction with pedicled TRAM flaps: An outcomes analysis of 117 consecutive patients. Plast Reconstr Surg. 2008;121: 1-8.
41. Giacalone PL, Bricout N, Dantas MJ, Daure's JP, Laffarque F. Achieving symmetry in unilateral breast reconstruction: 17 years experience with 683 patients. Aesthetic Plast Surg. 2002; 26:299-302.
42. Losken A, Carlson GW, Bostwick J III, Jones GE, Culbertson JH, Schoemann M. Trends in unilateral breast reconstruction and management of the contralateral breast: The Emory experience. Plast Reconstr Surg. 2002;110:89-97.
43. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362-1367.
44. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203- 5209.
45. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: A report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-2562.
46. McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy: Trends in use from 1995 through 2005. Cancer 2009;115:5404-5412.
47. Han E, Johnson N, Glissmeyer M, et al. Increasing incidence of bilateral mastectomies: The patient perspective. Am J Surg. 2011;201:615-618.
48. Murphy RX Jr, Adkinson JM, Namey T, Eid S, Bleznak A. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy. Ann Plast Surg. 2010;64:684-687.
49. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-695.
50. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158-2164.